ArticleResearch integrity and peer review2025
Policies on artificial intelligence chatbots among academic publishers: a cross-sectional audit.
Article in Research integrity and peer review, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Disclosure is not documentation: an open science framework for documenting generative AI use in scholarly research and publication workflows.Research integrity and peer review · 2026Article
- Linguistic shifts in dental scientific writing in the large language model era.Research integrity and peer review · 2026Article
- Prevalence and Content of Generative Artificial Intelligence Use Policies in Iranian Medical Science Journals.Medical journal of the Islamic Republic of Iran · 2026Article
- A structured framework for effective and responsible generative artificial intelligence chatbot prompt engineering throughout the scientific process: a comprehensive guide for the health and medical researcher.Frontiers in artificial intelligence · 2026Review
- Prompt engineering for generative artificial intelligence chatbots in health research: A practical guide for traditional, complementary, and integrative medicine researchers.Integrative medicine research · 2025Article
- Attitudes and perceptions of biomedical journal editors in chief towards the use of artificial intelligence chatbots in the scholarly publishing process: a cross-sectional survey.Research integrity and peer review · 2025Article
- Policies on artificial intelligence chatbots among academic publishers: a cross-sectional audit.Research integrity and peer review · 2025Article
- Artificial intelligence policies in neurology journals: a cross-sectional analysis.Frontiers in neurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundArtificial intelligence (AI) chatbots are novel computer programs that can generate text or content in a natural language format. Academic publishers are adapting to the transformative role of AI chatbots in producing or facilitating scientific research. This study aimed to examine the policies established by scientific, technical, and medical academic publishers for defining and regulating the authors' responsible use of AI chatbots.
methodsThis study performed a cross-sectional audit on the publicly available policies of 162 academic publishers, indexed as members of the International Association of the Scientific, Technical, and Medical Publishers (STM). Data extraction of publicly available policies on the webpages of all STM academic publishers was performed independently, in duplicate, with content analysis reviewed by a third contributor (September 2023-December 2023). Data was categorized into policy elements, such as 'proofreading' and 'image generation'. Counts and percentages of 'yes' (i.e., permitted), 'no', and 'no available information' (NAI) were established for each policy element.
resultsA total of 56/162 (34.6%) STM academic publishers had a publicly available policy guiding the authors' use of AI chatbots. No policy allowed authorship for AI chatbots (or other AI tool). Most (49/56 or 87.5%) required specific disclosure of AI chatbot use. Four policies/publishers placed a complete ban on the use of AI chatbots by authors.
conclusionsOnly a third of STM academic publishers had publicly available policies as of December 2023. A re-examination of all STM members in 12-18 months may uncover evolving approaches toward AI chatbot use with more academic publishers having a policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.